» Articles » PMID: 26686106

Fabrication, Characterization and Cytotoxicity Studies of Ionically Cross-linked Docetaxel Loaded Chitosan Nanoparticles

Overview
Journal Carbohydr Polym
Specialty Biochemistry
Date 2015 Dec 22
PMID 26686106
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The present investigation aimed at the fabrication and characterization of ionically cross-linked docetaxel (DTX) loaded chitosan nanoparticles (DTX-CH-NP) using ionic gelation technique with sodium tripolyphosphate (TPP) as the cross-linking agent. The formulated nanoparticles were characterized in terms of particle size, drug entrapment efficiency (EE), scanning electron microscopy (SEM), in vitro release and cytotoxicity studies. Formulation factors (chitosan, TPP and drug concentration) were examined systematically for their effects on size of the nanoparticles. The average size of the nanoparticles was observed to be in the range of 159.2 ± 3.31 to 220.7 ± 2.23 nm with 78-92% encapsulation efficiency (EE). The in vitro cytotoxicity studies on breast cancer cell lines (MDA-MB-231) revealed the advantages of DTX-CH-NP over pure DTX with approximately 85% cell viability reduction. The results indicate that systematic modulation of the surface charge and particle size of ionically cross-linked nanoparticles can be readily achieved with the right control of critical processing parameters. Thus, DTX-CH-NP presents a promising delivery alternative for breast cancer treatment.

Citing Articles

Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies.

Al-Shadidi J, Al-Shammari S, Al-Mutairi D, Alkhudhair D, Thu H, Hussain Z Int J Nanomedicine. 2024; 19:8373-8400.

PMID: 39161363 PMC: 11332424. DOI: 10.2147/IJN.S472433.


A combination of chitosan nanoparticles loaded with celecoxib and kartogenin has anti-inflammatory and chondroprotective effects: Results from an model of osteoarthritis.

Nabizadeh Z, Nasrollahzadeh M, Kruppke B, Nasrabadi D Heliyon. 2024; 10(10):e31058.

PMID: 38803939 PMC: 11128867. DOI: 10.1016/j.heliyon.2024.e31058.


Biomimetic nanodrug blocks CD73 to inhibit adenosine and boosts antitumor immune response synergically with photothermal stimulation.

Li T, Zhang X, Shi C, Liu Q, Zhao Y J Nanobiotechnology. 2024; 22(1):214.

PMID: 38689291 PMC: 11059694. DOI: 10.1186/s12951-024-02487-4.


Evaluation of the anti-inflammatory activity of fisetin-loaded nanoparticles in an in vitro model of osteoarthritis.

Nabizadeh Z, Nasrollahzadeh M, Shabani A, Mirmohammadkhani M, Nasrabadi D Sci Rep. 2023; 13(1):15494.

PMID: 37726323 PMC: 10509168. DOI: 10.1038/s41598-023-42844-1.


Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments.

Imam S, Gilani S, Bin Jumah M, Rizwanullah M, Zafar A, Ahmed M Polymers (Basel). 2022; 14(18).

PMID: 36145851 PMC: 9504729. DOI: 10.3390/polym14183705.